RxDoctor Payments Data

Vincent Chan

Critical Care Medicine · Sylmar, CANPI 1891929956

Payments from drug & device makers

$1,258in general payments, 2019–2025

Across 47 payments — averaging $26.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insmed, Inc.$129
  • Boehringer Ingelheim$127
  • United Therapeutics Corporation$127
  • Amgen$120
  • Merck$91
  • Actelion Pharmaceuticals US, Inc.$88
  • plus $576 from 16 others

What the payments were for

  • Food & beverage$1,258100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,258 in reported general payments places this provider in the 65th percentile of 715 critical care medicine providers in California.

See all critical care medicine providers in California

Other critical care medicine in Sylmar

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →